Status:
COMPLETED
Ketamine Versus Lidocaine Nebulization for Awake Fiberoptic Intubation
Lead Sponsor:
Ain Shams University
Conditions:
Anesthesia
Eligibility:
All Genders
21-50 years
Phase:
PHASE4
Brief Summary
This randomized double-blinded study is performed to compare ketamine versus lidocaine for nebulization for awake nasal fiberoptic intubation as regard efficacy and side effects.
Detailed Description
Difficult airway is one of the major challenges facing anesthesiologists. This challenge is compounded when the patient is treated while awake. The additional burden is to complete this procedure comf...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I and II of both sexes with body weight from 60-90 kg, and planned for elective awake nasal fiberoptic intubation due to expected difficulty in airway management (e.g. limited mouth opening, trismus, mandibular/ maxillary swellings or tumors, ludwig's angina, or other indications).
Exclusion
- body weight \< 60 kg or \> 90 kg
- uncooperative, with mental or psychological problems
- known allergy to any of the study drugs
- pregnancy
- hypertension
- cardiac disease
- liver or renal impairment
- epilepsy,
- asthmatic,
- previous bad experience of awake intubation,
- emergency operations or
- coagulation abnormalities
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03414879
Start Date
January 15 2018
End Date
July 25 2019
Last Update
November 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University hospitals
Cairo, Egypt, 11591